Pricing Log in Create free account

Bolt Biotherapeutics, Inc. (BOLT) vs Vyome Holdings, Inc. (HIND)

Bolt Biotherapeutics, Inc. and Vyome Holdings, Inc. are both Biotechnology companies. Bolt Biotherapeutics, Inc. and Vyome Holdings, Inc. are of similar size ($12.3M and $11.4M). Bolt Biotherapeutics, Inc. grew revenue faster over the last twelve months: 12.8% against −67.1%. Bolt Biotherapeutics, Inc. has the higher net margin (−611.5% vs −8,711.7%) and the lower return on invested capital (−143.8% vs 0.00%). Across the 18 metrics below, Bolt Biotherapeutics, Inc. leads on 12 and Vyome Holdings, Inc. on 6.

Valuation

Metric BOLT HIND Biotechnology median
P/E n/m n/m 10.26
P/S 2.35 87.06 9.18
P/B 0.87 1.55 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 2.51 124.58 8.98
Earnings yield (251.76%) (222.25%) (34.89%)
Free cash flow yield (279.10%) (49.36%) (24.52%)

Profitability

Metric BOLT HIND Biotechnology median
Gross margin 100.00% 52.77% 65.16%
Operating margin (654.53%) (9,184.82%) 0.00%
Net margin (611.47%) (8,711.71%) 0.00%
Free cash flow margin (655.72%) (4,298.00%) 0.00%
Return on equity (111.65%) (172.10%) (50.12%)
Return on assets (49.62%) (124.23%) (45.60%)
Return on invested capital (143.75%) 0.00% 0.00%

Growth

Metric BOLT HIND Biotechnology median
Revenue growth (TTM) 12.79% (67.10%) 6.26%
EPS growth (last fiscal year) 45.91% 99.92% 29.88%
Revenue growth, 5-year CAGR 101.61% (50.98%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BOLT HIND Biotechnology median
Debt to equity 1.47 0.00 0.00
Current ratio 2.61 4.37 4.89
Net debt to EBITDA 0.21 0.48 1.01

Dividend

Metric BOLT HIND Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BOLT HIND Biotechnology median
Market cap 12.29m 11.44m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack